• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    WW Appoints Doctor Adam Kaufman as Senior Vice President of Healthcare and Diabetes

    2/26/21 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary
    Get the next $WW alert in real time by email

    NEW YORK, Feb. 26, 2021 /PRNewswire/ -- WW International, Inc. (NASDAQ: WW), a human-centric technology company powered by the world's leading commercial weight management program, announced today that Adam Kaufman, PhD has joined the company as Senior Vice President, Healthcare and Diabetes. In this role, Adam will manage WW Health Solutions, the existing business, and lead the development of a dedicated offering specifically designed for people with diabetes. He will sit on the senior leadership team and report to Nick Hotchkin, Chief Operating Officer.

    Adam Kaufman

    "WW Health Solutions continues to be a key strategic growth lever for our business and we will now also focus on the broader healthcare market as well as diabetes as a core WW consumer offering," said Nick Hotchkin, WW Chief Operating Officer. "We are thrilled to have Adam join the team. In addition to his deep expertise in diabetes, he has unique experience in applying technology to improvements in healthcare services."

    Adam comes to WW from DTxL - Boston Consulting Group's and Abundant Venture Partners' joint venture - where he led its launch as a leader in digital therapeutics. Prior to that, Adam spent five years at Canary Health where he oversaw the launch of a new online business offering and mobile technology enabled healthcare services. Prior to Canary Health, Adam served in leadership roles at healthcare institutions including DPS Health where he was President & CEO and at dLife where he was General Manager and Executive Vice President.

    "I am excited to join the WW team to lead these important growth initiatives and extend support through the healthcare ecosystem," said Adam Kaufman. "In the U.S. alone, more than 30 million people are living with diabetes. Despite the high correlation between obesity and Type 2 diabetes, the population is under-represented within the WW community. I am looking forward to applying my experience and knowledge to further scale our impact and advancing our relationships with employers, providers, payors and physicians."

    About WW International, Inc.
    WW (formerly Weight Watchers) is a human-centric technology company powered by the world's leading commercial weight management program. As a global wellness company, we inspire millions of people to adopt healthy habits for real life. Through our comprehensive digital app, expert Coaches and engaging experiences, members follow our proven, sustainable, science-based program focused on food, activity, mindset and sleep. Leveraging nearly six decades of expertise in nutritional and behavioral change science, providing real human connection and building inspired communities, our purpose is to democratize and deliver holistic wellness for all. To learn more about the WW approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com. 

    About WW Health Solutions
    WW Health Solutions partners with employers, payors and health providers to implement wellness and weight management tools. WW Health Solutions aims to propel happier, healthier, more productive workplaces and make wellness more accessible. WW Health Solutions supports partners, including Fortune 500 companies, that span industries such as healthcare, government, education and manufacturing.

    For more information, contact:
    Nicole Penn, WW
    VP Corporate Communications
    917.734.0802
    [email protected]

    SOURCE WW International, Inc.

    Get the next $WW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WW

    DatePrice TargetRatingAnalyst
    9/15/2025Market Perform
    CJS Securities
    7/26/2024$6.50 → $1.25Overweight → Equal-Weight
    Morgan Stanley
    1/3/2024$8.00Underweight
    Barclays
    12/20/2023$14.00Buy
    Guggenheim
    9/27/2023$4.00 → $10.00Sell → Hold
    Craig Hallum
    7/26/2023$5.00 → $13.00Equal-Weight → Overweight
    Morgan Stanley
    4/11/2023$3.80 → $13.00Neutral → Buy
    Goldman
    3/8/2023$4.00Hold → Sell
    Craig Hallum
    More analyst ratings

    $WW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo® Available Through LillyDirect

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company's newly FDA-approved oral GLP-1, Foundayo® (orforglipron) through its Med+ offering and affiliated medical groups. The addition gives members a new once-daily, injection-free option for adults with obesity or overweight with weight-related medical problems and further expands the company's growing portfolio of FDA-approved oral GLP-1 treatments, all within a clinically supported program designed to help them succeed. Through Weight Watchers Med+, clinically eligible memb

    4/9/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Announces Board Committee Appointments

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors' standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors: Audit Committee: Gene Davis (Chair), Sue Gove, Carney Hawks and Nikolaj Sjoqvist;Compensation and Benefits Committee: Carney Hawks (Chair), Gene Davis and Lisa Gavales;Nominating and Corporate Governance Committee: Nikolaj Sjoqvist (Chair), Gene Davis and Sue Gove; andStrategy and Finance Committee: Gene Davis (Chair), Lisa Gavales, Car

    4/9/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cotter Debra

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    4/17/26 6:01:03 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Cotter Debra

    3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    4/17/26 6:00:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Gavales Lisa A

    3 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    4/17/26 5:59:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    SEC Filings

    View All

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/20/26 7:35:07 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/17/26 5:00:14 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form 8-K/A filed by WW International Inc.

    8-K/A - WW INTERNATIONAL, INC. (0000105319) (Filer)

    4/9/26 7:35:06 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CJS Securities initiated coverage on WW

    CJS Securities initiated coverage of WW with a rating of Market Perform

    9/15/25 10:08:29 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WW downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously

    7/26/24 7:46:12 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Barclays initiated coverage on WW with a new price target

    Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00

    1/3/24 8:36:04 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Kelly Denis F bought $49,897 worth of shares (64,500 units at $0.77), increasing direct ownership by 80% to 145,421 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:13:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Sistani Sima bought $48,555 worth of shares (65,000 units at $0.75), increasing direct ownership by 32% to 267,410 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:06:22 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Leadership Updates

    Live Leadership Updates

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

    NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed accomplished executives, Lisa Gavales and Sue Gove, as independent members of the Company's Board of Directors, effective April 7, 2026. Ms. Gavales and Ms. Gove will serve as directors until the Company's 2026 annual meeting of shareholders and are expected to stand for election at the annual meeting. Following these appointments, the Board consists of six directors, all of whom are independent. Lisa Gavales and Sue Gove are highly regarded consumer brand leaders with distinct exp

    4/7/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Announces Leadership Transition and Board Updates

    Office of the CEO Established to Oversee Business Operations  Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors ("the Board"). These actions follow Tara Comonte's departure from the Company, effective March 31, 2026.  The Company's Board of Directors has initiated a comprehensive search for a permanent successor with the support of a l

    4/3/26 2:09:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Financials

    Live finance-specific insights

    View All

    Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

    2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026  Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh

    3/16/26 7:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system b

    2/27/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Schedules Third Quarter 2025 Earnings Conference Call

    NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co

    10/30/25 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/14/24 6:06:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/8/24 10:40:45 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by WW International Inc.

    SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)

    2/14/24 6:58:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary